We are pioneering healthcare to improve patients’ lives around the world
Our Purpose
Making medicines more affordable, more available, and better than before
We, at Tiefenbacher Group, are driven by a deep sense of purpose: since 1963 we are pioneering healthcare to improve patients’ lives around the world.
We believe that there are always ways to make pharmaceuticals more affordable, more available and better than before. This belief drives our curiosity and inspires us to continuously challenge the status quo. We love to pave new ways and to push frontiers to make a meaningful impact on patients’ lives.
We work together as one Tiefenbacher Group, providing best-in-class solutions along the entire pharmaceutical value chain. We distribute raw materials and develop, manufacture, and register affordable, value added, and innovative medicines. This broad competence enables us to pioneer healthcare holistically as we can connect ideas and expertise to create better healthcare solutions.
Our company values: curiosity driven – excellence focused – patient centered
Always challenging the status quo – this is how we work, this is how we think
Our three values define who we are and what special attitudes we have. They are central to how we behave as individuals, and collectively as an organization to achieve our purpose of making pharmaceuticals more affordable, more available, and better than before.
Our purpose and our values tie us together across functions, across business units, and across the world. By working together as one Tiefenbacher Group we tap into our full potential and stay at the forefront of our field to shape a healthier tomorrow.
Organization Structures
Connected and collaborating in agile structures
Our B2B and B2C business unites is systematically oriented toward our operational business. Our agile cross-functional company structure makes us stronger and better to change tomorrow’s health together.
Our company structure
We, at TIEFENBACHER GROUP, have often demonstrated to excel in our field, to retain talent, and to innovate fastest. Our broad competence and vertical company structures enables us to pioneer healthcare holistically. We are pushing beyond what’s possible – always from a patient-centric approach – and are bringing forward novel healthcare solutions for people around the world.
Corporate Responsibility
Improving patients’ lives through sustainable business
We, at Tiefenbacher Group, know that our responsibility as a global healthcare company goes beyond medicine. We understand sustainability as behaving responsibly towards society and our planet – in our day-to-day work. Being commercially successful and operating responsibly is how we will generate sustainable returns.
We demonstrate our commitment to doing business responsibly in a very meaningful and tangible way by building a healthier and more sustainable future. Check out how we act responsibly in our daily business within the Tiefenbacher Group to fulfill our purpose of improving patients´ lives sustainably.
Tiefenbacher Group achieves EcoVadis silver medals
Proven commitment to sustainable business
We are excited and proud to announce that we have achieved two silver medals in the recent EcoVadis Sustainability ratings, placing the company among the top 15% of all rated companies worldwide. The achievement of the silver ratings represents an important recognition that underlines Tiefenbachers commitment to Corporate Social Responsibility based on four main areas: Environment, Labour & Human Rights, Ethics and Sustainable Procurement.
Governance & Business Ethics
Responsible corporate governance
We are committed to responsible corporate governance – throughout our whole organization and pharmaceutical value chain.
Our Environmental Policy, Human Rights & Labor Policy as well as our Sustainable Procurement Policy are available upon request. For these documents or any questions regarding our sustainability journey or other ESG-related inquiries, please send an email to sustainability@tiefenbacher.com.
Further details
For us at Tiefenbacher Group, compliance means more than adhering to legal requirements, voluntary obligations and internal company guidelines. Compliance is a question of attitude: reliability, honesty, credibility, and integrity are part of our DNA and the basis of our sustainable business success.
The Code of Conduct and the Whistleblower Platform are two important components of our corporate governance.
Our Code of Conduct describes how we want to do business at TIEFENBACHER GROUP. It provides guidance on how to deal with the most important integrity and legal issues in our daily work – with our colleagues, our customers, our business partners, and other third parties.
With our Whistleblower Platform Tiefenbacher Group offers employees and external stakeholders the opportunity to report violations of legal provisions and internal company regulations anonymously. Every report is examined in detail by an external body, suspicious cases are investigated, and any infringements are consistently pursued. Our Whistleblower Portal is a dedicated communication channel operated by a third party and available 24 hours a day, 365 days a year
Our History: Pioneering healthcare since 1963
Our milestones and continued growth at Tiefenbacher
From a distributor of Active Pharmaceutical Ingredients (APIs) to a purpose-driven healthcare company with a global footprint. We have always been powered by a strong commitment to make a difference with our products and services. Founded in 1963 as the world’s first exclusive agency for active pharmaceutical ingredients (APIs), Tiefenbacher has been grown into a leading healthcare company providing innovative and best-in-class solutions along the entire pharmaceutical value chain.
From initial idea to market entry: Today we distribute APIs and develop, manufacture, and register finished dosage forms (FDFs). In over 60 years of our company history, we have shown an outstanding track record in anticipating new developments as well as launching new businesses.
2026
Expansion of production block 1 at Tiefenbacher Laboratories India
2025
Opening of new R&D centre at Tiefenbacher Laboratories India
2024
Opening of new high potency site at Tiefenbacher Laboratories India
2021
Site Expansion at Delorbis Cyprus
2020
Start of Oysta (Drug-eHealth combination)
2019
First NCE approval for innovative sleeping medicine
2016
Foundation of Tiefenbacher Medical Devices
2014
Launch of axunio Pharma (Branded Pharmaceuticals)
2014
Foundation of AET Pharma Inc. USA
2009
Acquisition of Delorbis Cyprus (Manufacturing / Branded Pharmaceuticals)
2003
Opening of AET Laboratories India (R&D and Manufacturing)
1995
First generic drug development of finished dosage form
1963
Foundation by Alfred E. Tiefenbacher (API distribution)
Pioneer of the pharmaceutical industry
Our founder Alfred E. Tiefenbacher – a family-owned company since 1963
Our entrepreneurial spirit is firmly anchored in our founder and owner family since 1963.
The foundation of TIEFENBACHER GROUP´s success story was the pioneer spirit of the company´s founder and namesake Alfred E. Tiefenbacher (*1917, +1993). Until today his unique entrepreneur mind is our driving force of achieving better health solutions by always challenging the status quo.
As we have growing, we are proud to have maintained the agile, entrepreneurial spirit on which we were founded, continuously evolving with our customers and the industry to expand our services and network. Through all of this, we continue to exercise the same level of flexibility and responsiveness that is embedded in our DNA. This combination translates to superior quality to make pharmaceuticals more affordable, more available, and better than before.
